NG2 proteoglycan expression by pericytes in pathological microvasculature.
Ozerdem
Ugur
U
Cancer Research Center, Burnham Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA. ozerdem@burnham.org
Monosov
Edward
E
Stallcup
William B
WB
D000818:Animals; D000941:Antigens / Q000096:biosynthesis*; D003315:Cornea / Q000098:blood supply*; D005260:Female; D018496:Hyperoxia; D008024:Ligands; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008833:Microcirculation / Q000378:metabolism*; D008856:Microscopy, Fluorescence; D009389:Neovascularization, Pathologic; D010100:Oxygen / Q000378:metabolism; D020286:Pericytes / Q000378:metabolism*; D011509:Proteoglycans / Q000096:biosynthesis*; D020797:Receptor, Platelet-Derived Growth Factor beta / Q000378:metabolism*; D012160:Retina / Q000502:physiology; D013997:Time Factors; D000099216:Chondroitin Sulfate Proteoglycan 4
D000941:Antigens; D008024:Ligands; D010100:Oxygen; D011509:Proteoglycans; D020797:Receptor, Platelet-Derived Growth Factor beta; D000099216:Chondroitin Sulfate Proteoglycan 4